Drug Shortage Report for INNOHEP
| Report ID | 98537 |
| Drug Identification Number | 02358182 |
| Brand name | INNOHEP |
| Common or Proper name | tinzaparin sodium |
| Company Name | LEO PHARMA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | TINZAPARIN SODIUM |
| Strength(s) | 20000UNIT |
| Dosage form(s) | SOLUTION |
| Route of administration | SUBCUTANEOUS |
| Packaging size | 10 x 0.9mL |
| ATC code | B01AB |
| ATC description | ANTITHROMBOTIC AGENTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2019-11-12 |
| Estimated end date | 2019-12-20 |
| Actual end date | 2019-12-19 |
| Shortage status | Resolved |
| Updated date | 2019-12-20 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 6 ADELAIDE STREET EAST, SUITE 200 TORONTO, ONTARIO CANADA M5C 1H6 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v8 | 2019-12-20 | English | Compare |
| v7 | 2019-12-19 | French | Compare |
| v6 | 2019-12-19 | English | Compare |
| v5 | 2019-11-26 | French | Compare |
| v4 | 2019-11-26 | English | Compare |
| v3 | 2019-11-13 | English | Compare |
| v2 | 2019-11-12 | French | Compare |
| v1 | 2019-11-12 | English | Compare |
Showing 1 to 8 of 8